Novel role of Ezh2 in age-related gastric motility dysfunctions
Novel role of Ezh2 in age-related gastric motility dysfunctions
批准号:
10133065
负责人:
Yujiro NA Hayashi
金额:
$35.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31
关键词:
AddressAgeAgingAnorexiaBody WeightCell AgingCellsComplexConsumptionDataDependenceDietary intakeDifferentiated GeneElderlyEnhancersEnteralEpigenetic ProcessFamilyFunctional disorderGastric EmptyingGastric TissueGastrointestinal tract structureGenomicsHomologous GeneImmuneImpairmentIndividualInflammatoryInterstitial Cell of CajalKnowledgeLeadLinkLongevityMalignant NeoplasmsMechanicsMediatingMedicalModelingMolecularMouse Mammary Tumor VirusMusMuscle ContractionNeuromodulatorNeuronsOrganPRC1 ProteinPacemakersPathway interactionsPharmacologyPhasePreventionQuality of lifeReflex controlRegulationReportingRepressionRoleSatiationSignal TransductionSmooth MuscleSmooth Muscle MyocytesSphincterStomachSymptomsTherapeuticTissuesUp-RegulationWNT Signaling PathwayWorkage relatedagedbasebeta catenincell motilitycholinergicdietaryearly satietyepigenetic regulationfrailtygene repressionhealthy aginghistone methyltransferaseimprovedintegration siteinterstitial cellmedical attentionmortalitymotor disorderneurotransmissionnew therapeutic targetnodal myocytenovelpreventrecruitreduced food intakesarcopeniaself-renewalsenescencestem cell agingstem cell self renewalstem cellsweight maintenance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Age-related gastric motor dysfunctions include reduced compliance and impaired slow wave
activity. However, these dysfunctions are often underestimated due in part to nonspecific
symptoms and lack of sufficient medical attention. Although these conditions are not themselves
fatal, they have been shown to contribute to early satiety and consequent reduced food intake.
Surprisingly, recent reports have linked low dietary intake to increased cancer mortality and
overall mortality in elderly individuals and aged mice, suggesting that reduced food intake due to
gastric dysfunctions may contribute to increased overall mortality in elderly individuals. Thus, a
growing body of evidence indicates the significance of studying age-related gastric motor
dysfunctions to promote healthy aging. Previously we reported a profound age-related loss of
interstitial cells of Cajal (ICC), pacemaker and neuromodulator cells of the GI tract. ICC loss
was accompanied by a depletion of ICC stem cells (ICC-SC); and these changes could be
linked to specific gastric dysfunctions and reduced food intake. A critical gap in our knowledge is
the lack of understanding of the mechanisms of age-related ICC loss and related gastric motor
dysfunctions. Stem cell senescence has been proposed as a major factor of aging-related organ
dysfunctions, and in preliminary studies we found that overactive Wnt/β-catenin signaling can
indeed lead to ICC-SC senescence via increased Trp53. Another important mechanism
proposed to underlie stem cell senescence is altered function of histone methyltransferase
enhancer of zeste homolog 2 (Ezh2), which we found to be upregulated in senescent ICC-SC
and gastric tissues obtained from older mice and individuals. However, the relationship between
Wnt-induced senescence and Ezh2 remains unclear. Therefore, my overall hypothesis is that
ICC-SC senescence, a putative mechanism of age-related ICC loss, is due to overactive Wnt
signaling-induced recruitment of Ezh2 and consequent repression of genes important for ICC-
SC self-renewal and differentiation; and senescence can be prevented by Ezh2 inhibition.
Specific Aim 1 is to provide definitive evidence that overactive Wnt signaling can lead to ICC-SC
senescence via Trp53 upregulation. Specific Aim 2 is to unravel epigenetic mechanisms of ICC-
SC senescence underlying aging-associated ICC depletion. Specific Aim 3 is to determine the
functional consequence of aging-associated ICC depletion. This project may reveal a novel,
pharmacologically realizable therapeutic approach to prevent ICC-SC senescence and age-
related gastric dysfunctions leading to improved quality of life. This project also aims to discover
a previously unrecognized mechanism of stem cell aging, which may be of general significance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel role of Ezh2 in age-related gastric motility dysfunctions
-
批准号:10379343
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2020
-
负责人:Yujiro NA Hayashi
-
依托单位:
Novel role of Ezh2 in age-related gastric motility dysfunctions
-
批准号:10598001
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2020
-
负责人:Yujiro NA Hayashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: